Open Your FREE Demat Account Now!

Indraprastha Medical Corporation Ltd. Share Price

NSE
BSE

NSE : INDRAMEDCO

BSE : 532150

Sector : Healthcare

N/A
indicator
1D
1M
3M
6M
1Y
5Y
empty graph

Day's Range

Low

₹346.20

High

₹363.75

Price Summary

Previous Close ₹353.05
Day's Range ₹346.20 - ₹363.75
Open ₹353.00
52 Week Range ₹293.65 - ₹546.30
Volume 4,53,084
Market Cap ₹0.00
Previous Close ₹352.45
Day's Range ₹346.30 - ₹362.10
Open ₹351.35
52 Week Range ₹293.50 - ₹546.60
Volume 38,200
Market Cap ₹0.00

Stocks Summary

Trade Value ( ₹ in Lacs) 1,600.96
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 1.13
Price/Earning (TTM) 16.82
TTM EPS (₹) 20.96
P/E Ratio 18.55
Book Value(₹) 3.97
PAT Margin (%) 12.39
Face Value (₹) 10.00
ROCE(%) 37.70
Trade Value ( ₹ in Lacs) 135.56
Market Cap (₹ in Mn) 0.00
Dividend Yield(%) 1.13
Price/Earning (TTM) 16.82
TTM EPS (₹) 20.96
P/E Ratio 18.55
Book Value(₹) 3.97
PAT Margin (%) 12.39
Face Value (₹) 10.00
ROCE(%) 37.70

Financials

Particulars QTR FY (₹ in Millions) Annual FY (₹ in Millions)
Net sales 3810.3 13563.6
Expenses N/A N/A
PBT 663.1 2163.2
Operating profit 0.0 0.0
Net profit 494.6 1609.9

Shareholding Pattern

Promoters (% Holding)

51.00%

Mutual funds (% Holding)

0.91%

Non-Institution (% Holding)

44.84%

FI/Banks/Insurance (% Holding)

0.00%

Government (% Holding)

0.00%

FII

2.39%

About Indraprastha Medical Corporation Ltd.

Founded 1988
NSE Symbol INDRAMEDCO

Peer Comparision

Stocks Name Market Cap (Cr)(₹) Market Price (₹) 52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd. 4,48,687.64 1,870.05 1,583.70 - 1,583.70
Divi's Laboratories Ltd. 2,95,080.27 11,115.45 5,647.50 - 5,647.50
Torrent Pharmaceuticals Ltd. 1,77,677.43 4,671.20 3,672.30 - 3,672.30
Lenskart Solutions Ltd. 1,28,551.39 736.50 0.00 - 0.00
Laurus Labs Ltd. 1,26,433.06 2,340.00 917.95 - 917.95
Apollo Hospitals Enterprise Ltd. 1,25,112.06 8,701.35 6,696.50 - 6,696.50
Zydus Lifesciences Ltd. 1,19,969.79 1,202.70 835.50 - 835.50
Dr. Reddy's Laboratories Ltd. 1,15,852.16 1,387.00 1,101.00 - 1,101.00
Cipla Ltd. 1,11,730.92 1,383.00 1,165.70 - 1,165.70
Mankind Pharma Ltd. 1,07,612.70 2,605.35 1,909.70 - 1,909.70
no-content No Records Found

Latest News

Nov
17
2026
EQUITY Posted on Nov 17th 2026

Indraprastha Medical Corporation informs about clarification

Indraprastha Medical Corporation has clarification that there is no information or announcement (including impending announcement) to be made by the Company which, in our opinion, may have a bearing on the operation/ performance of the company (which includes all price sensitive information, etc) and which is required to be disclosed under regulation 30 of SEBI LODR. The company is not aware of any information that led to the movement in the Volume/price of the shares of the company.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
19
2026
EQUITY Posted on Oct 19th 2026

Indraprastha Medical Corporation informs about board meeting

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indraprastha Medical Corporation has informed that a meeting of the Board of Directors of the Company will be held on Thursday, 29th October, 2026, to consider and approve, the unaudited financial results for the quarter and half year ended 30th September, 2026.

The above information is a part of company’s filings submitted to BSE.

Read More
Sep
22
2026
EQUITY Posted on Sep 22nd 2026

Indraprastha Medical Corporation informs about trading window closure

Indraprastha Medical Corporation has informed that the Trading Window for dealing in shares of the Company shall remain closed for all designated persons including Promoters, Directors, KMPs and other Designated Employee and their connected persons from 1st October, 2026, until 48 hours after the declaration of the unaudited financial results by the Company for quarter ending 30th September, 2026
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
17
2026
EQUITY Posted on Nov 17th 2026

GlaxoSmithKline Pharmaceuticals informs about postal ballot notice

GlaxoSmithKline Pharmaceuticals has informed that it enclosed a copy of Postal Ballot Notice pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, which is being sent to the Members of the Company seeking their approval for Related Party Transactions with GSK Biological S.A. (Belgium). In compliance with the Circulars of the Ministry of Corporate Affairs, the said Notice is being sent electronically only to those Members, whose names appear in the Register of Members/ List of Beneficial Owners as received from National Securities Depository (‘NSDL’)/ Central Depository Services (India) (‘CDSL’) and who have registered their e-mail addresses in respect of electronic holdings with NSDL/CDSL through the concerned Depository Participants and in respect of physical holdings with the Company’s Registrar and Share Transfer Agent (RTA) - KFin Technologies as on Friday, 13th November 2026 (cut-off date). The e-voting shall commence on Wednesday, 18th November, 2026 and ends at 05.00 PM (IST) on Thursday, 17th December, 2026. The copy of the said Notice is also available on the website of the Company at https://india-pharma.gsk.com/en-in/investors/shareholder-information/postal-ballot/ and on the website of Kfintech https://evoting.kfintech.com/.
The above information is a part of company’s filings submitted to BSE.
Read More
Nov
17
2026
EQUITY Posted on Nov 17th 2026

AstraZeneca Pharma India informs about letter of intent

AstraZeneca Pharma India has informed that the Company has signed a Letter of Intent (‘LOI’) with Strand Life Sciences (‘Strand’), a genomics research and diagnostics company and a subsidiary of Reliance Industries, to explore opportunities to collaborate in healthcare in India. The Company and Strand are not related parties, and the execution of the LOI does not constitute a related party transaction. Communication in relation to the above is disseminated through the LinkedIn handle of the Company and is accessible at AstraZeneca India. The above information is also being made available on the website of the Company at www.astrazeneca.com/india.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the current share price of Indraprastha Medical Corporation Ltd. ?

The current share price of Indraprastha Medical Corporation Ltd. is ₹353.05 as of 2026-11-17.

The market capitalisation of Indraprastha Medical Corporation Ltd. is ₹3,231.01 as of 2026-11-17.

The 1-year return of Indraprastha Medical Corporation Ltd. is -194.85% as of 2026-11-17.

The P/E ratio of Indraprastha Medical Corporation Ltd. is 18.55 as of 2026-11-18.

The 52-week high and low of Indraprastha Medical Corporation Ltd. are ₹546.30 and ₹293.65, respectively, as of 2026-11-17.

The dividend yield of Indraprastha Medical Corporation Ltd. is 1.1349% as of2026-11-17.

You can buy Indraprastha Medical Corporation Ltd. shares through a registered stockbroker or trading platform. Bajaj Markets partners with trusted brokers to help you open a demat account. This is the first step to trading, making it easier to invest in your desired shares.

The Managing Director of Indraprastha Medical Corporation Ltd. is .

When investing in a company’s stock, you may consider key factors such as its fundamentals, including financial health, historical performance, and growth potential. Assess the consistency of its performance, market conditions, and industry trends. Additionally, evaluate your own risk tolerance while reviewing aspects like quarterly earnings, management quality, and sector performance, for taking a well-informed decision.

You can track stock performance on online platforms through live market updates, historical charts, and news alerts. Regular analysis and stock alerts allow you to stay informed about significant price changes and events affecting the stock.

Common stock provides voting rights and the potential for dividends based on company performance, while in case of preferred stock, stockholders receive fixed dividends and have priority over common stockholders in asset distribution but generally lack voting rights.

Stock investments carry market risks, including price volatility, economic shifts, and sector-specific issues. Managing risk can involve diversifying your portfolio, setting stop-loss orders, and staying informed about market trends to make timely decisions.

Market capitalisation, or market cap, is the total value of a company’s outstanding shares and is calculated by multiplying the stock price by the total shares. It classifies companies as large-cap, mid-cap, or small-cap, reflecting their size, stability, and potential risk level in the stock market.

View More

People Also Ask

What does Indraprastha Medical Corporation Ltd do?

Indraprastha Medical Corporation Ltd operates hospitals and healthcare facilities while providing medical treatments, diagnostics, specialised healthcare services, and patient care solutions.

Indraprastha Medical Corporation Ltd operates within the healthcare and hospital management sector in India’s medical services industry.

Indraprastha Medical Corporation Ltd is listed on both the National Stock Exchange and the Bombay Stock Exchange.

The NSE trading symbol of Indraprastha Medical Corporation Ltd is INDRAMEDCO, which is used for stock exchange identification and trading.

Indraprastha Medical Corporation Ltd was incorporated in 1988 and later established healthcare operations through hospital and medical infrastructure development.

Indraprastha Medical Corporation Ltd provides healthcare services including cardiology, oncology, diagnostics, emergency care, surgeries, specialised treatments, and hospital management services.

Indraprastha Medical Corporation Ltd competes with hospital chains, healthcare service providers, and multi-speciality medical institutions operating across India.

View More

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore